anmeldenAnalysen von Peter Welford
| 29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 27.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 19.04.22 | Roche Buy | Jefferies & Company Inc. | |
| 19.04.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 19.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 19.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 17.03.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 02.03.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 16.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.02.22 | Roche Buy | Jefferies & Company Inc. | |
| 10.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 09.02.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 04.02.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 04.02.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.02.22 | Roche Buy | Jefferies & Company Inc. | |
| 02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
| 06.01.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 15.12.21 | GSK Buy | Jefferies & Company Inc. | |
| 15.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.12.21 | Roche Buy | Jefferies & Company Inc. | |
| 07.12.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 07.12.21 | GSK Buy | Jefferies & Company Inc. | |
| 07.12.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.11.21 | EVOTEC Buy | Jefferies & Company Inc. | |
| 16.11.21 | QIAGEN Hold | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
| 29.10.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.10.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.10.21 | GSK Buy | Jefferies & Company Inc. | |
| 20.10.21 | Roche Buy | Jefferies & Company Inc. | |
| 07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
| 07.10.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.10.21 | Roche Buy | Jefferies & Company Inc. | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 14.09.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
